Brooks, E. D., Landau, D. J., Brown, T. T., Asfaw, Y. G., & Koeberl, D. D. (2015). 701. Long-Term Complications of Glycogen Storage Disease Type IA in the Dog Model Treated With Gene Replacement Therapy. In Molecular Therapy (Vol. 23, pp. S279–S279). Elsevier BV. https://doi.org/10.1016/s1525-0016(16)34310-6

Brooks, Elizabeth D., Dustin J. Landau, Talmage T. Brown, Yohannes G. Asfaw, and Dwight D. Koeberl. “701. Long-Term Complications of Glycogen Storage Disease Type IA in the Dog Model Treated With Gene Replacement Therapy.” In Molecular Therapy, 23:S279–S279. Elsevier BV, 2015. https://doi.org/10.1016/s1525-0016(16)34310-6.

Brooks ED, Landau DJ, Brown TT, Asfaw YG, Koeberl DD. 701. Long-Term Complications of Glycogen Storage Disease Type IA in the Dog Model Treated With Gene Replacement Therapy. In: Molecular Therapy. Elsevier BV; 2015. p. S279–S279.

Brooks, Elizabeth D., et al. “701. Long-Term Complications of Glycogen Storage Disease Type IA in the Dog Model Treated With Gene Replacement Therapy.” Molecular Therapy, vol. 23, Elsevier BV, 2015, pp. S279–S279. Crossref, doi:10.1016/s1525-0016(16)34310-6.

Brooks ED, Landau DJ, Brown TT, Asfaw YG, Koeberl DD. 701. Long-Term Complications of Glycogen Storage Disease Type IA in the Dog Model Treated With Gene Replacement Therapy. Molecular Therapy. Elsevier BV; 2015. p. S279–S279.